Roth et al.8 did an experiment in a 48-well micro chemotaxis chamber which suggests that cell migration of gliomas cells in presence of additional decoy receptors DcR3 is significantly decreased when compared to migration in presence of only normal receptors CD95. The gene discussed is FAS; the disease is central nervous system cancer.